Stocks To Watch Today on February 5, 2025: Tata Power, Lemon Tree Hotels, Sun Pharma & More in Focus

On Wednesday, February 5, 2025, the Indian benchmark indices Sensex and Nifty 50 are expected to open higher, following gains in global markets. Check out a few stocks that might be in focus during the trading session.

• Tata Power

Tata Power‘s Q3 consolidated net profit surged to ₹1,030 crore, up from ₹953 crore year-on-year (Y-o-Y). Revenue climbed to ₹15,400 crore, compared to ₹14,651 crore. EBITDA jumped to ₹3,352 crore, rising from ₹2,417 crore, while the EBITDA margin improved significantly to 21.78% from 16.50%.

• Lemon Tree Hotels

Lemon Tree Hotels reported a sharp rise in Q3 consolidated net profit, which increased to ₹62.5 crore from ₹35.4 crore Y-o-Y and ₹29.6 crore sequentially. Revenue climbed to ₹360 crore, up from ₹289 crore Y-o-Y. EBITDA rose to ₹184 crore from ₹142 crore, with the EBITDA margin expanding to 51.86% from 48.80%.

• Metropolis Healthcare

Metropolis Healthcare‘s Q3 consolidated net profit improved to ₹31.4 crore, compared to ₹27.15 crore in the previous year. Revenue increased to ₹323 crore, up from ₹290 crore. EBITDA stood at ₹72 crore, higher than ₹64.8 crore, while the EBITDA margin remained stable at 22.31%, marginally up from 22.28%.

• Sun Pharma

Sun Pharma announced that Philogen has completed patient enrollment for the Phase III Fibrosarc trial in soft tissue sarcoma.

• Whirlpool of India

Whirlpool of India‘s Q3 consolidated net profit jumped to ₹44 crore, compared to ₹28 crore Y-o-Y. Revenue expanded to ₹1,700 crore, rising from ₹1,526 crore. EBITDA grew to ₹69.3 crore, up from ₹62.7 crore, while the EBITDA margin stood at 4.06%, slightly lower than 4.08%.

• Indian Energy Exchange (IEX)

Indian Energy Exchange (IEX) recorded a traded volume of 10,910 MU in January, marking a 16% increase Y-o-Y. The average DAM price was ₹4.43/unit, reflecting a 24% decline from the previous year.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.